Surgery Today

, Volume 30, Issue 3, pp 255–261

The Prognostic Value of Quality-of-Life Scores: Preliminary Results of an Analysis of Patients with Breast Cancer

  • Kojiro Shimozuma
  • Hiroshi Sonoo
  • Kiyoshi Ichihara
  • Katsuhiro Tanaka
Original Articles

Abstract

This study was conducted to elucidate the prognostic value of patient-assessed quality-of-life (QL) scores in cancer patients. QL was assessed in 47 consecutive patients with advanced or end-stage breast cancer using the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD). The data collected from 19 of the 47 patients, who completed QL questionnaires more than twice before dying of cancer, were analyzed. The relationships between the QL scores and subsequent survival were examined at two assessment points, being the first and last assessment points of each of the 19 patients; corresponding respectively to median survival times of 14 and 4 months. The prognostic significance of the changes in QL scores that occurred over 3 months before the last assessment point was also examined. At the last assessment point, the scores of the physical aspects of QL were significantly related to survival. The change in scores of both overall QL and the physical aspects of QL were also significant predictors of survival. On the other hand, neither the scores nor the change in scores of the psychological and social aspects of QL was significant. This study indicates that both QL scores and changes in QL scores are promising prognostic predictors.

Key Words

breast cancer prognosis quality of life palliative care 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shimozuma K, Sonoo H, Ichihara K, Kurebayashi J, Miyake K, Yoshikawa K, Ota K (1994) Analysis of factors associated with quality of life in breast cancer patients after surgery. Breast Cancer 1:123–129PubMedCrossRefGoogle Scholar
  2. 2.
    Shimozuma K, Sonoo H, Ichihara K, Miyake K, Kurebayashi J, Ota K, Kiyono T (1995) The impacts of breast conserving treatment and mastectomy on the quality of life in early-stage breast cancer patients. Breast Cancer 2:35–43PubMedCrossRefGoogle Scholar
  3. 3.
    Shimozuma K, Sonoo H, Ichihara K (1995) Analysis of the factors influencing the quality of life of patients with advanced or recurrent breast cancer. Surg Today 25:874–882PubMedCrossRefGoogle Scholar
  4. 4.
    Shimozuma K, Tominaga T, Hayashi K, Kondo J, Kosaki G (1991) Notification of cancer in breast cancer patients (in Japanese with English abstract). Jpn J Cancer Chemother 18:2147–2153Google Scholar
  5. 5.
    Shimozuma K, Tominaga T, Hayashi K, Kosaki G (1991) Evaluation of quality of life in breast cancer patients (in Japanese with English abstract). J Jpn Soc Cancer Ther 26:1504–1510Google Scholar
  6. 6.
    Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135PubMedCrossRefGoogle Scholar
  7. 7.
    Greer S, Morris T, Pettingale KW (1979) Psychological response to breast cancer: effect on outcome. Lancet 2:785–787PubMedCrossRefGoogle Scholar
  8. 8.
    Greer S, Morris T, Pettingale KW, Haybittle J (1990) Psychological response to breast cancer and 15-year outcome. Lancet 335: 49–50PubMedCrossRefGoogle Scholar
  9. 9.
    Pettingale KW, Morris T, Greer S (1985) Mental attitudes to cancer: an additional prognostic factor. Lancet i:750CrossRefGoogle Scholar
  10. 10.
    Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet ii:888–891CrossRefGoogle Scholar
  11. 11.
    Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M, Forbes JF (1992) for the Australian New Zealand Breast Cancer Trials Group. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10:1833–1838PubMedGoogle Scholar
  12. 12.
    Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG (1994) Quality of life of cancer patients with different prognoses. Quality Life Res 3:143–154CrossRefGoogle Scholar
  13. 13.
    Ruckdeschel JC, Piantadosi S, and the Lung Cancer Study Group (1991) Quality of life assessment in lung surgery for bronchogenic carcinoma. J Theor Surg 6:201–205Google Scholar
  14. 14.
    Kaasa S, Mastekaasa A, Lund E (1989) Prognostic factos for patients with inoperable non-small cell lung cancer, limited disease. The important of patients’ subjective experience of disease and psychosocial well-being. Radiother Oncol 15:235–242PubMedCrossRefGoogle Scholar
  15. 15.
    Shimozuma K, Sonoo H, Ichihara K (1995) Analysis of factors that improve quality of life of patients with advanced or recurrent breast cancer (in Japanese with English abstract). Jpn J Cancer Chemother 22:1095–1102Google Scholar
  16. 16.
    Shimozuma K, Sonoo H, Tanaka K, Ichihara K (1997) Analysis of factors that improve quality-of-life of patients with advanced or recurrent breast cancer (in Japanese with English abstract). Jpn J Breast Cancer 12:58–67Google Scholar
  17. 17.
    Eguchi K, Kurihara M, Shimozuma K, Hotta T, Murakami M, Suzuki N, Ishikawa K, Ogawa H, Tominaga T, Kobayashi K, Shimizu H, Tsuboi K (1993) The QOL questionnaire for cancer patients treated with anticancer drugs (in Japanese). J Jpn Soc Cancer Ther 28:1140–1144Google Scholar
  18. 18.
    Kurihara M, Shimizu H, Tsuboi K, Kobayashi K, Murakami M, Eguchi K, Shimozuma K (1999) Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psycho-oncology 8:355–363PubMedCrossRefGoogle Scholar
  19. 19.
    Lorish CD, Maisiak R (1986) The face scale: a brief, nonverbal method for assessing patient mood. Arthritis Rheum 29:906–909PubMedCrossRefGoogle Scholar
  20. 20.
    Zubrod CG, Schneiderman M, Frei E III, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens AH Jr (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11:7–33CrossRefGoogle Scholar
  21. 21.
    Union Internationale Contre le Cancer, Breast (ICD-O 174) (1987) In: Harmer MH (ed) TNM classification of malignant tumours, 4th edn. Springer, Berlin, pp 93–99Google Scholar
  22. 22.
    Drettner B, Ahlbom A (1983) Quality of life and state of health for patients with cancer in the head and neck. Acta Otolaryngol 96:307–314PubMedCrossRefGoogle Scholar
  23. 23.
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de-Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F for the European Organization for Research and Treatment of Cancer Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natal Cancer Inst 85:365–376CrossRefGoogle Scholar
  24. 24.
    Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: development and validation. J Clin Oncol 2:472–483PubMedGoogle Scholar
  25. 25.
    Priestman T, Baum M, Jones V, Fobes J (1977) Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J 1:1248–1250PubMedCrossRefGoogle Scholar
  26. 26.
    Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients: a concise QL index for use by physicians. J Chron Dis 34:585–597PubMedCrossRefGoogle Scholar
  27. 27.
    Coates AS, Dillenbeck CF, McNeil DR, Kaye SB, Sims K, Fox RM, Woods RL, Milton GW, Solomon J, Tattersall MH (1983) On the receiving end — II. Linear analog self assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol 19:1633–1637PubMedCrossRefGoogle Scholar
  28. 28.
    Shavit Y, Lewis JW, Terman W, Gale RP, Leibeskind JC (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223:188–190PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2000

Authors and Affiliations

  • Kojiro Shimozuma
    • 1
  • Hiroshi Sonoo
    • 1
  • Kiyoshi Ichihara
    • 2
  • Katsuhiro Tanaka
    • 1
  1. 1.Department of Surgery, Breast and Thyroid DivisionKawasaki Medical SchoolKurashikiJapan
  2. 2.Department of Clinical PathologyKawasaki Medical SchoolKurashikiJapan

Personalised recommendations